Story perspectives

10 Million Americans Turn to Psychedelic Microdosing for Mental Health

1/26/2026

46 6

Summary

Story summary

A RAND Corporation study found 10 million U.S. adults microdosed psychedelics in 2025, signaling growing interest in their mental health benefits.
Microdosing involves taking small doses without seeking an altered state and is used to manage anxiety, depression, and enhance creativity.
Psilocybin was the most used psychedelic, followed by MDMA and Amanita muscaria mushrooms.
Researchers noted the prevalence of Amanita muscaria, which can cause nausea and seizures.

1 of 1

Story summary

A RAND Corporation study found 10 million U.S. adults microdosed psychedelics in 2025, signaling growing interest in their mental health benefits.
Microdosing involves taking small doses without seeking an altered state and is used to manage anxiety, depression, and enhance creativity.
Psilocybin was the most used psychedelic, followed by MDMA and Amanita muscaria mushrooms.
Researchers noted the prevalence of Amanita muscaria, which can cause nausea and seizures.